The FDA Sends Letters to 20 Companies in Attempt to Rein in Stem Cell Industry

April 5, 2019

(Washington Post) – The letters are part of an ongoing attempt by the FDA to rein in the booming industry , which critics say has injured dozens of patients and cheated thousands more. In recent years, hundreds of clinics have have popped up selling stem cell procedures — not covered by insurance, unproven by science and unauthorized by the government — that purveyors claim can treat ailments ranging from creaky knees to Alzheimer’s, Crohn’s disease and multiple sclerosis.

Recommended Reading